Low Dose Cyclosporin and Methotrexate Therapy in Diabetes

• Status: Completed
• Trial end date: 1994-06-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to determine whether treatment with low dose cyclosporin and methotrexate can inhibit the development of new onset diabetes mellitus

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Georgetown University
• Treatments: Cyclosporine; Cyclosporins; Methotrexate

Criteria

Inclusion Criteria:

• Diagnosis of Type1 diabetes mellitus and be obtaining insulin therapy for less than 4 weeks

Exclusion Criteria:

• Ketoacidosis

• Body weight over 110% of ideal weight

• Condition where immunosuppression is contraindicated

• Abnormal liver or renal function tests